Related Experiment Video
Updated: Apr 28, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Imbalance of type I and II interferon pathways is associated with pain perception in Sjogren's disease: a real-life
Krzysztof Proc1, Paweł Gajdanowicz2, Lucyna Korman1
1Department of Rheumatology and Internal Medicine, Institute of Internal Medicine, Wroclaw Medical University, Wroclaw, Poland.
Introduction:
Activation of interferon (IFN) pathways is a central mechanism in the pathogenesis of Sjögren's disease (SjD) and systemic lupus erythematosus (SLE). While type I IFN signatures have been extensively characterized, the systemic relevance of circulating type III IFNs and the clinical implications of the relative balance between IFN types I, II, and III remain insufficiently explored.
Methods:
In this real-life, exploratory study, plasma concentrations of IFN-α2, IFN-β, IFN-γ, IFN-λ1, and IFN-λ2 were measured in patients with SjD (n = 59), SLE (n = 35), and healthy controls (n = 30). Disease activity and patient-reported outcomes were assessed using ESSDAI, ESSPRI, and SLEDAI-2K. In addition to absolute IFN concentrations, ratios between IFN subtypes were analyzed to reflect interferon pathway balance. Non-parametric statistical analyses with correction for multiple testing were applied.
Results:
Absolute plasma concentrations of individual IFN subtypes did not differ significantly between the study groups. In SjD, exploratory correlation analyses revealed a significant association between the IFN-α2/IFN-γ ratio and pain severity assessed by ESSPRI (Spearman's ρ = 0.48, adjusted p < 0.05). This association was independent of systemic inflammatory activity measured by ESSDAI. Furthermore, selected IFN ratios involving IFN-λ differed between SLE and SjD, suggesting disease-specific patterns of interferon balance. No significant associations were observed between IFN parameters and SLEDAI-2K scores in SLE.
Conclusions:
These findings indicate that the relative balance between interferon pathways, rather than absolute circulating IFN levels, may be clinically relevant in SjD, particularly with respect to patient-reported pain. Interferon subtype ratios may represent exploratory biomarkers of immune dysregulation. Further studies integrating systemic, tissue-level, and transcriptomic approaches are warranted to validate these observations.
More Related Videos
06:37Temporomandibular Joint Pain Measurement by Bite Force and Von Frey Filament Assays in Mice
Published on: September 13, 2024
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Related Concept Videos
Type I Diabetes II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Type II Diabetes II: Pathophysiology
Chronic Inflammation: Introduction
The JAK-STAT Signaling Pathway